Beranda › Eksim › South Carolina
Uji klinis Eksim di South Carolina
5 studi untuk Eksim mencari peserta di lokasi di South Carolina.
Teks studi resmi (Bahasa Inggris)
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- National Allergy and Asthma Research, LLC, North Charleston
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07527923A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Medical University of South Carolina - Department of Dermatology, Charleston
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
- Medical University of South Carolina - Walton Research Building, Charleston
- dan 1 lainnya
Menerima pesertaFase 3
Usia 6 hingga 11 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06807268A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
- Tribe Clinical Research, LLC, Greenville
Menerima pesertaFase 3
Usia 2 hingga 11 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06807281A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 12, Anderson
Menerima pesertaFase 2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07037901A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- National Allergy and Asthma, North Charleston
- Spartanburg Medical Research, Spartanburg
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05995964Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.